Specific depressive symptoms predict remission to aripiprazole augmentation in late‐life treatment resistant depression

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1166|33|2|e330-e335

ISSN： 0885-6230

Source： INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol.33, Iss.2, 2018-02, pp. : e330-e335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Late-Life Depression: Rationalizing Pharmacological Treatment Options

By  

Gerontology, Vol. 48, Iss. 6, 2002-10 ,pp. : 392-400

Karger

Access to resources Recommend Favorite

Cognitive functioning throughout the treatment history of clinical late‐life depression

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 885-6230, Iss. 10, 2015-10 ,pp. : 1076-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cognitive functioning throughout the treatment history of clinical late‐life depression

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 10, 2015-10 ,pp. : 1076-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quetiapine augmentation of treatment-resistant depression: a comparison with lithium

By Dorée Jean-Pierre   Des Rosiers Joël   Lew Viviane   Gendron Alain   Elie Robert   Stip Emmanuel   Tourjman S. Valérie  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite

Examining the association between late‐life depressive symptoms, cognitive function, and brain volumes in the context of cognitive reserve

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 6, 2015-06 ,pp. : 614-622

John Wiley & Sons Inc

Access to resources Recommend Favorite